Skip to content

Psilocybin: all studies

Page 409 of 440: studies 4,081 to 4,090 of 4,392, newest first. Back to the psilocybin overview

Research

Hallucinogens and Their Therapeutic Use: A Literature Review.

Journal of Psychiatric Practice September 1, 2019 Matthew J Begola, Jason E Schillerstrom 20 citations

The exploration of possible therapeutic benefits of hallucinogenic substances has undergone a revitalization in the past decade. This literature review investigated the published literature regarding the psychotherapeutic uses of hallucinogens in psychiatric disorders. The results showed that a variety of substances have been evaluated in the treatment of psychiatric disorders, including...

DOI: 10.1097/pra.0000000000000409 (opens in new tab) Full text (opens in new tab) Psychedelics Hallucinogens Entheogens Psychedelic drugs +12

Accounting for Microdosing Classic Psychedelics

Journal of Drug Issues August 30, 2019 Blake Beaton, Heith Copes, Megan Webb et al. 13 citations

Microdosing classic psychedelics (e.g., LSD [lysergic acid diethylamide] and psilocybin) is the practice of taking small amounts of these substances to bring about various positive life changes. Little is known about the subjective experiences and perceptions of those who engage in the practice. Accordingly, we use the sociology of accounts as a theoretical framework to explore the ways that...

PSYCHEDELIC DRUGS IN PALLIATIVE CARE

August 12, 2019 Beatriz Martins, Afonso Homem de Matos, Manuel Sardinha

Background and aimsPhysical suffering of a person under palliative care is frequently associated to psychological (or existential) suffering. In fact, people with potentially untreatable diseases present a higher prevalence of depressive symptoms and anxiety than general population. Nevertheless, conventional therapeutic options seem to be insufficient.Inspired by 1950-1960u2019s studies, some...

DOI: 10.26226/morressier.5d1a036a57558b317a13fb9a (opens in new tab) Palliative care Intensive care medicine Nursing

A new “inside-out” perspective on general factor p

European Psychiatry August 5, 2019 Thomas M. Kelley, William F. Pettit, Jack Pransky et al. 6 citations

This theoretical article revives a classical bridging construct, canalization, to describe a new model of a general factor of psychopathology. To achieve this, we have distinguished between two types of plasticity, an early one that we call 'TEMP' for 'Temperature or Entropy Mediated Plasticity', and another, we call 'canalization', which is close to Hebbian plasticity. These two forms of...

DOI: 10.1016/j.eurpsy.2019.06.009 (opens in new tab) Variance accounting Psychopathology Plasticity Hebbian theory +6

Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.

Neuroimage June 24, 2019 Carla Pallavicini, Martina G. Vilas, Mirta Villarreal et al. 66 citations

Classic serotonergic psychedelics are remarkable for their capacity to induce reversible alterations in consciousness of the self and the surroundings, mediated by agonism at serotonin 5-HT2A receptors. The subjective effects elicited by dissociative drugs acting as N-methyl-D-aspartate (NMDA) antagonists (e.g. ketamine and phencyclidine) overlap in certain domains with those of serotonergic...

DOI: 10.1016/j.neuroimage.2019.06.053 (opens in new tab) Brain activity Brainwaves Neural activity Electrical activity +23

Entheogens in Christian art: Wasson, Allegro, and the Psychedelic Gospels

Journal of Psychedelic Studies June 1, 2019 Jerry B. Brown, Julie M. Brown 6 citations

In light of new historical evidence regarding ethnomycologist R. Gordon Wasson’s correspondence with art historian Erwin Panofsky, this article provides an in-depth analysis of the presence of entheogenic mushroom images in Christian art within the context of the controversy between Wasson and philologist John Marco Allegro over the identification of a Garden of Eden fresco in the 12th century...

DOI: 10.1556/2054.2019.019 (opens in new tab) Fresco Context archaeology Christianity Medieval art +6

The “Kamasutra” temples of India: A case for the encoding of psychedelically induced spirituality

Journal of Psychedelic Studies May 29, 2019 Meena Maillart-Garg, Michael Winkelman 21 citations

The essay proposes that entheogenic mushrooms and shamanic experiences are encoded in the Khajuraho Temples of India. Erotic sculptures of Khajuraho have statues with limbs depicted in strange positions, separated from the body or with orientations that are anatomically impossible. These represent dismemberment experiences typical of shamanic and mystical initiation, a phenomenon with...

Psychedelic-assisted therapies: The past, and the need to move forward responsibly

International Journal of Drug Policy May 25, 2019 John Gardner, Adrian Carter, Kerry O’Brien et al. 23 citations

Recent clinical studies illustrate that psychedelics such as LSD and psilocybin may represent much-needed new treatment options for mood disorders and alcohol and other drug use disorders. More clinical studies are required to confirm the safety and efficacy of psychedelic-assisted therapies, but the cultural stigma that has surrounded psychedelics since the 1960s has hindered research. This...

Sacred Plants and Mental Health in Latin America

May 22, 2019 Oscar Espin, European Institute For Multidisciplinary Studies On Human Rights And Science - Knowmad Institut 1 citation preprint

Abstract Sacred plants have a number of phenomena that revolve around their ritual and medicinal use, as well as being seen as carrying a bond with the sphere of the sacred. México is the country that has the greatest diversity of sacred plants in the Americas because its indigenous groups have a magical-religious relationship with them. In the beginning of the study of sacred plants,...

DOI: 10.5281/zenodo.7235793 (opens in new tab) Latin americans Mental health Traditional medicine

Narrative identity, rationality, and microdosing classic psychedelics

International Journal of Drug Policy May 8, 2019 Megan Webb, Heith Copes, Peter S. Hendricks 75 citations

BackgroundMicrodosing involves ingesting a small dose of a classic psychedelic (e.g., LSD and psilocybin) at regular intervals for prolonged periods. The practice is said to reduce anxiety, improve mood, and offer several creative and practical benefits to users. Using the narrative identity theoretical framework, our aim was to explore the experiences of those who microdosed classic...